Oak Associates’s QuidelOrtho QDEL Stock Holding History

Oak Associates’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-19,774	Closed	-$1.69M	–	144
2022 Q4	$1.69M	Buy	+19,774	New	+$1.67M	0.14%	90

Other funds holding QDEL

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Oak Associates's QDEL Position: Q1 2023 in Review

Oak Associates sold out of QuidelOrtho (QDEL) in Q1 2023, closing a stake of 19,774 shares — an estimated $1.69M sold.

Oak Associates first reported a position in QDEL in Q4 2022 and held it in 1 quarter. The position peaked at $1.69M in Q4 2022. 331 funds tracked by Wall St. Rank hold QDEL as of Q1 2023.

Oak Associates reported no remaining QuidelOrtho position as of Q1 2023 after selling out during the quarter.
Oak Associates sold 19,774 QuidelOrtho shares in Q1 2023, an estimated $1.69M.
Oak Associates first reported a position in QuidelOrtho in Q4 2022 and held it in 1 quarter.
Oak Associates's QuidelOrtho position peaked at $1.69M in Q4 2022.
331 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2023.

Based on Oak Associates's 13F filing for Q1 2023, filed 11 May 2023.